Comment on: “The Predictive Value of NLR, PLR, LMR, NPAR and D-Dimer on the Efficacy and Prognosis of First-Line Immunotherapy for Extensive-Stage Small Cell Lung Cancer” [Letter]

Huazhen Wu,1 Jia Liao,2 Lishan Hu,3 Siwen Li4 1Department of Radiotherapy Oncology, The Qingyuan Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s Hospital, Guangdong, 511518, People’s Republic of China; 2Department of Tumor Chemotherapy, The Qingyuan Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s Hospital, Guangdong, 511518, People’s Republic of China; 3Department of Health Management, The Qingyuan Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s Hospital, Guangdong, 511518, People’s Republic of China; 4Department of Thoracic Surgery, The Qingyuan Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s Hospital, Guangdong, 511518, People’s Republic of ChinaCorrespondence: Siwen Li, Department of Thoracic Surgery, Qingyuan People’s Hospital, No. 35 Yinquan North Road, Qingcheng District, Qingyuan, Guangdong, People’s Republic of China, Email [email protected]